The development and validation of novel analytical methods adapted for a selection of anticancer drugs, both in bulk form and within pharmaceutical dosage formulations. There is an escalating demand for precise and reliable analytical techniques in pharmaceutical research, this investigation aims to address the critical need for robust methodologies specific to anticancer medications. Through meticulous experimentation and validation processes, the proposed methods exhibit efficacy in accurately quantifying the targeted drugs, ensuring compliance with regulatory standards and facilitating quality control in manufacturing processes. By employing advanced analytical techniques, including chromatography and spectroscopy, this research advances the field's capability to assess the potency and purity of anticancer compounds in various pharmaceutical formulations. The findings not only contribute to enhancing drug development and production but also hold significant implications for clinical applications, fostering improved therapeutic outcomes and patient care in the fight against cancer.